News

SelectScience Editorial Article of the Year Award

SelectScience have announced an Olink-sponsored article from Professor Leo Joosten on his research on COVID-19 as their drug ...

Olink Explore 1536 nominated for SelectScience award

Olink Explore 1536 has been nominated for the Scientists’ Choice Awards shortlist 2021 by SelectScience, in the category, “Best New ...

Olink Explore available as kits

After a highly successful introduction via fee-for-service at our Olink Analysis Service labs in Uppsala and Boston, the ...

Olink to provide proteomics data from 53,000 UK Biobank participants

We are proud to announce that the Olink® Explore 1536 platform will be used in a project to measure plasma ...

Longitudinal proteomic profiling of high-risk patients with COVID-19

In this study, longitudinal protein profiling with five different Olink® Target 96 panels was used to measure circulating proteins in ...

Plasma ACE2 and risk of death or cardiometabolic diseases

Using Olink's assay for the protein ACE2, researchers at Hamilton Health Sciences in Ontario, Canada found clear associations between ...

Update of our Target 96 Development panel (Oct 2020)

In response to customer feedback and as part of Olink’s commitment to improve and develop our offering, a change ...

MGH/Olink collaboration to investigate the plasma proteomic signatures of COVID-19 patients

In one of the first major protein biomarker studies run on the new Olink® Explore 1536 platform, Olink has collaborated ...

Multisystem Inflammatory Syndrome in Children with COVID-19

A study by Petter Brodin’s group at the Karolinska Institute has looked into an aspect of the COVID-19 ...

Immune response in mild versus severe COVID-19 infections

A study by researchers at Stanford University and other institutions reveals how the immune system goes awry leading to severe ...